A phase II study of FOLFOXIRI with bevacizumab in untreated metastatic colorectal cancer patients: A UGT1A1 genotype and safety results (QUATTRO study)

Takeshi Kato, Takayuki Yoshino, Kei Muro, Kentaro Yamazaki, Tatsuro Yamaguchi, Eiji Oki, Shigeyoshi Iwamoto, Akihito Tsuji, Goro Nakayama, Yasunori Emi, Tetsuo Touyama, Masato Nakamura, Masahito Kotaka, Hideaki Bando, Yoshinori Kagawa, Hiroya Taniguchi, Takeharu Yamanaka, Akiyoshi Kanazawa

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)
元の言語英語
ページ(範囲)iii9-iii10
ジャーナルAnnals of Oncology
28
DOI
出版物ステータス出版済み - 6 2017

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

これを引用